| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |